Sequoia Financial Advisors LLC Increases Stock Holdings in Encompass Health Corporation (NYSE:EHC)

Sequoia Financial Advisors LLC boosted its position in Encompass Health Corporation (NYSE:EHC) by 6.7% during the 1st quarter, HoldingsChannel reports. The firm owned 2,727 shares of the company’s stock after purchasing an additional 172 shares during the period. Sequoia Financial Advisors LLC’s holdings in Encompass Health were worth $276,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also bought and sold shares of EHC. Colonial Trust Co SC purchased a new position in Encompass Health in the fourth quarter worth about $29,000. Transce3nd LLC purchased a new position in Encompass Health in the fourth quarter worth about $40,000. CBIZ Investment Advisory Services LLC boosted its position in Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock worth $42,000 after purchasing an additional 127 shares during the last quarter. Signaturefd LLC raised its stake in shares of Encompass Health by 21.6% in the fourth quarter. Signaturefd LLC now owns 704 shares of the company’s stock worth $65,000 after buying an additional 125 shares during the period. Finally, C M Bidwell & Associates Ltd. raised its stake in shares of Encompass Health by 73.6% in the fourth quarter. C M Bidwell & Associates Ltd. now owns 750 shares of the company’s stock worth $69,000 after buying an additional 318 shares during the period. 97.25% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Truist Financial reaffirmed a “buy” rating and issued a $135.00 price objective (up previously from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. Royal Bank Of Canada raised their price objective on Encompass Health from $110.00 to $125.00 and gave the stock an “outperform” rating in a research note on Monday, April 28th. UBS Group raised their price objective on Encompass Health from $117.00 to $130.00 and gave the stock a “buy” rating in a research note on Monday, April 28th. KeyCorp raised their price objective on Encompass Health from $122.00 to $135.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 27th. Finally, Wall Street Zen downgraded Encompass Health from a “strong-buy” rating to a “buy” rating in a research note on Friday, June 6th. Eight investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Buy” and an average price target of $127.00.

Encompass Health Stock Up 0.1%

Shares of EHC opened at $119.04 on Friday. The business’s 50 day moving average is $119.27 and its 200 day moving average is $105.22. The company has a market capitalization of $12.00 billion, a PE ratio of 24.60, a price-to-earnings-growth ratio of 2.41 and a beta of 0.88. Encompass Health Corporation has a 12-month low of $82.74 and a 12-month high of $123.13. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.81.

Encompass Health (NYSE:EHC) last issued its earnings results on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.18. The company had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a return on equity of 17.63% and a net margin of 8.97%. The firm’s quarterly revenue was up 10.6% on a year-over-year basis. During the same quarter last year, the company earned $1.12 EPS. Research analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.57%. The ex-dividend date is Tuesday, July 1st. Encompass Health’s dividend payout ratio (DPR) is presently 14.05%.

Insider Activity at Encompass Health

In other Encompass Health news, CEO Mark J. Tarr sold 118,384 shares of the firm’s stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $121.53, for a total transaction of $14,387,207.52. Following the completion of the transaction, the chief executive officer owned 527,070 shares in the company, valued at $64,054,817.10. This trade represents a 18.34% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP John Patrick Darby sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $114.79, for a total value of $1,147,900.00. Following the transaction, the executive vice president owned 79,710 shares of the company’s stock, valued at $9,149,910.90. This represents a 11.15% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 132,663 shares of company stock valued at $16,034,082. 2.00% of the stock is owned by company insiders.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.